High presynaptic dopaminergic activity in children with Tourette's disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 38, Issue 1, 1999, Pages 86-94

  Ernst, Monique ^a,b,c   Zametkin, Alan J ^a   Jons, Peter H ^a   Matochik, John A ^a   Pascualvaca, Daisy ^a   Cohen, Robert M ^a,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Caudate nucleus; Midbrain; Movement disorder; Positron emission tomography; Presynaptic dopaminergic activity; Tics; Fluorine 18 fluorodopa

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBIDOPA; FLUORINE 18; FLUORODOPA; TRACER; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CAUDATE NUCLEUS; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME REGULATION; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENCEPHALON; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; TIC;

EID: 0032954721     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199901000-00024     Document Type: Article

References (73)

1. Abercrombie ED, Bonatz AE, Zigmond MJ (1990), Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525:36-44
2. Alexinder G, Crutcher M (1990), Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271
3. American Psychiatric Association (1987), Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington, DC: American Psychiatric Association
4. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-JV). Washington, DC: American Psychiatric Association
5. Balthazar K (1956), Uber das anatomishe Substrat der generalisierten Tic-Krankheit (maladie des tics, Gilles de la Tourette): Entwicklungshemmung des Corpus Striatum. Arch Psychiatr Nervenkr 195:531-539
6. Braun AR, Stoetter B, Randolph C et al. (1993), The functional neuroanatomy of Tourette's syndrome: an FDG-PET study, I: regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 9:277-291
7. Castellanos FX, Giedd JN, Elia J et al. (1997), Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 36:589-596
8. Chase TN, Geoffrey V, Gillespie M, Burrows GH (1986), Structural and functional studies of Gilles de la Tourette syndrome. Rev Neural (Paris) 142: 851-855
9. Cohen DJ, Shaywitz BA, Caparulo B, Young JG, Bowers MB (1978), Chronic, multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 35:245-250
10. Dhawan B, Ishikawa T, Patlak C, Chaly T, Eidelberg D (1996), Combined FDOPA and 3-OMFDPET studies in Parkinsons disease: modeling issues and clinical significance of striatal dopa decarboxylase activity. In: Quantification of Brain Function Using PET, Myers R, Cunningham V, Bailey D, Jones T, eds. San Diego: Academic Press, pp 219-223
11. Doudet DJ, Aigner TG, McLellan CA, Cohen RM (1992a), Positron emission tomography with 18-F-dopa: interpretation and biological correlates in nonhuman primates. Psychiatry Res 45:153-168
12. Doudet DJ, McLellan CA, Aigner TG, Wyatt RJ, Cohen RM (1992b), Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-DOPA uptake in brain. J Nucl Med 33:1383-1389
13. Ernst M (1998), Dopaminergic function in ADHD. In: Dopaminergic Disorders: Novel Approaches for Drug Discovery and Development, IBC, ed. Southborough, MA: IBC, pp 235-260
14. Ernst M, Zametkin A, Matochik J et al. (1996), Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 334:1568-1604
15. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM (1998), Presynaptic dopaminergic activity in ADHD adults: a [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 18:5901-5907
16. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM (1997), Low medial prefrontal dopaminergic activity in autistic children (letter). Lancet 350:638
17. Friedhoff AJ (1977), Receptor sensitivity modification (RSM): a new paradigm for the potential treatment of some hormonal and transmitter disturbances. Compr Psychiatry 18:309-317
18. Garnett ES, Firnau G, Chan PK, Sood S, Belbeck LW (1978), [18F]Fluoro-DOPA, an analogue of DOPA and its use in direct external measurements of storage, degradation, and turnover of intracerebral dopamine. Proc Natl Acad Sci USA 75:464-467
19. Garnett ES, Firnau G, Nahmias C (1983), Dopamine visualized in the basal ganglia of living man. Nature 305:137-138
20. George MS, Robertson MM, Costa DC et al. (1994), Dopamine receptor availability in Tourette's syndrome. Psychiatry Res: Neuroimaging 55: 193-203
21. Gerfen CR (1992), The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15:285-320
22. Gershon ES, DeLisi LE, Hamovit J et al. (1988), A controlled family study of chronic psychosis. Arch Gen Psychiatry 45:328-336
23. Gjedde A, Leger GC, Cumming P et al. (1993), Striatal L-DOPA decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis. J Neurochem 61:1538-1541
24. Glick SD, Ross DA, Hough LB (1982), Lateral asymmetry of neurotransmitters in human brain. Brain Res 234:53-63
25. Golden GS (1988), The relationship between stimulant medication and tics. Pediatr Ann 17:405-406, 408
26. Gordon I, Rehavi M, Mintz M (1994), Bilateral imbalance in striatal DA-uptake controls rotation behavior. Brain Res 646:207-210
27. Goyette CH, Conners CK, Ulrich RF (1978), Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol 6:221-236
28. Grace AA (1995), The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Defend 37:111-129
29. Haber SN, Kowall NW, Vonsattel JP, Bird ED, Richardson EP (1986), Gilles de la Tourette's syndrome: a postmortem neuropathological and immunohistochemical study. J Neurol Sci 75:225-241
30. Hadjiconstantinou M, Wemlinger TA, Sylvia CP, Hubble JP, Neff NH (1993), Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J Neurochem 60:2175-2180
31. Hall M, Costa DC, Shields J, Heavens J, Robertson M (1990), Brain perfusion patterns with 99mTc-HMPAO/SPET in patients with Gilles de la Tourette syndrome. Nucl Med Suppl 27:243-245
32. Hyde TM, Aaronson BA, Randolph C, Weinberger DR (1995), Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins. Neurology 45:1176-1182
33. Jackson CW, Morton WA, Lydiard RB (1994), Pharmacologic management of obsessive-compulsive disorder. South Med J 87:310-321
34. Jastak S, Wilkinson GS (1984), The Wide Range Achievement Test, Revised. Wilmington, DE: Jastak Associates
35. Leckman JF, Cohen DJ (1983), Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research. Psychiatr Dev 1:301-316
36. Leckman JF, Riddle MA, Hardin MT et al. (1989), The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573
37. Levy F (1991), The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust N Z J Psychiatry 25:277-283
38. Malison RT, McDougle CJ, vanDyck CH et al. (1995), [123I]Beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 152:1359-1361
39. Martin WRW, Stoessl AJ, Adam MJ et al. (1986), Positron emission tomography in Parkinsons disease: glucose and DOPA metabolism. Adv Neurol 45:95-98
40. Martineau J, Barthelemy C, Jouve J, Muh JP, Lelord G (1992), Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Dev Med Child Neurol 34:593-603
41. Matsui T, Hirano A (1978), An Atlas of the Human Brain for Computerized Tomography. New York: Igaku-Shoin
42. McDougle CJ, Goodman WK, Price LH (1994), Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry 55(suppl):24-31
43. McLellan CA, Doudet DJ, Brucke T, Aigner TG, Cohen RM (1991), New rapid analysis method demonstrates differences in 6-[18F]fluoro-L-dopa plasma input curves with and without carbidopa in hemi-MPTP lesioned monkeys. Int J Rad Appl Instrum 42:847-854
44. Moriarty J, Costa DC, Schmitz B, Trimble MR, Ell PJ, Robertson MM (1995), Brain perfusion abnormalities in Gilles de la Tourette's syndrome. Br J Psychiatry 167:249-254
45. National Institute of Mental Health (1985), Special feature: rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:765-770
46. Peterson B, Riddle MA, Cohen DJ et al. (1993), Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images (see comments). Neurology 43:941-949
47. Peterson BS, Skudlirski P, Anderson AW et al. (1998), A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 55:326-333
48. Reich W, Weiner Z (1988), Diagnostic Interview for Children, Adolescents, and Parents. St Louis: Washington University
49. Richardson EP (1982), Neuropathological studies of Tourette syndrome. In: Gilles de la Tourettt Syndrome, Friedhoff AJ, Chase TN, eds. New York: Raven, pp 83-87
50. Riddle MA, Rasmusson AM, Woods SW, Hoffer PB (1992), SPECT imaging of cerebral blood flow in Tourette syndrome. Adv Neurol 58:207-211
51. Ross CA, Ruggiero DA, Reis DJ (1981), Afferent projections to cardiovascular portions of the nucleus of the tractus solitarius in the rat. Brain Res 223:402-408
52. Semple WE, Johnson JL, Cohen RM (1993), Reliability in positron emission tomography. In: Imaging Drug Action in the Brain, London ED, ed. Boca Raton, FL: CRC Press, pp 297-316
53. Seutin V, Verbanck P, Massotte L, Dresse A (1991), Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro. Brain Res 29:263-269
54. Shaffer D, Gould MS, Brasic J et al. (1983), A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231
55. Shapiro AK, Shapiro E (1982), Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of Tourette syndrome. Adv Neurol 35:383-386
56. Shapiro AK, Shapiro ES, Brown RD, Sweet RD (1978), Gilles de la Tourette Syndrome. New York: Raven
57. Shapiro AK, Shapiro ES, Wayne HL (1973), The symptomatology and diagnosis of Gilles de la Tourette's syndrome. J Am Acad Child Psychiatry 12:702-723
58. Singer HS, Butler IJ, Tune LE, Seifert WE, Coyle JT (1982), Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 12:361-366
59. Singer HS, Hahn IH, Moran TH (1991), Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 30:558-562
60. Singer HS, Reiss AL, Brown JE et al. (1993), Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 43:950-956
61. Singer HS, Walkup JT (1991), Tourette syndrome and other tic disorders: diagnosis, pathophysiology, and treatment. Medicine (Baltimore) 70:15-32
62. Singer HS, Wong DF, Brown JE et al. (1992), Positron emission tomography evaluation of dopamine d-2 receptors in adults with Tourette syndrome. Adv Neurol 58:233-239
63. Singer WD (1981), Transient Gilles de la Tourette syndrome after chronic neuroleptic withdrawal. Dev Med Child Neurol 23:518-521
64. Stoetter B, Braun AR, Randolph C et al. (1992), Functional neuroanatomy of Tourette syndrome limbic-motor interactions studied with FDGPET. Adv Neurol 58:213-226
65. Stone TW (1980), Adenosine and related compounds do not affect nerve terminal excitability in rat CNS. Brain Res 182:198-200
66. Torstenson R, Hartvig P, Langstrom B, Westerberg G, Tedroff J (1997), Differential effects of levodopa on dopaminergic function in early and advanced Parkinsons disease. Ann Neurol 41:334-440
67. Turjanski N, Sawle GV, Playford ED et al. (1994), PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J Neurol Neurosurg Psychiatry 57:688-692
68. Walkup JT, Rosenberg LA, Brown J, Singer HS (1992), The validity of instruments measuring tic severity in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 31:472-477
69. Wechsler D (1974), WISC-R Manual: Wechsler Intelligence Scale for Children-Revised. New York: Psychological Corporation
70. Wolf S, Jones D, Knable M et al. (1996), Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273:1225-1227
71. Wong DF, Harris JC, Naidu S et al. (1996), Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci U SA 93:5539-5543
72. Woodcock RW, Johnson BB (1977), Woodcock-Johnson Psychoeducational Battery Examiner's Manual Allen, TX: DLM Teaching Resources
73. Zhu MY, Jurio AV, Paterson I, Boulton AA (1993), Regulation of striatal L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. Eur J Pharmacol 238:157-164